RELEASE: BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Labs

(Information sent by the signatory company).

RELEASE: BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Labs

(Information sent by the signatory company)

Birmingham, March 1, 2023.

BioGX, a global provider of easy molecular diagnostic solutions since 2007, has announced the fulfillment of multiple initial orders for its portable pixl™ real-time PCR platform from customers across the United States, with immediate plans to expand production to meet demand. From the market

"We are very impressed with the response to the launch of our novel 'pixl' qPCR platform. Pixl is accelerating the validation and adoption of our broad multiplex syndromic panels available in our unique Xfree and Sample-Ready lyophilized formats," said Shazi Iqbal, Ph. D., CEO of BioGX.The pixl instrument is a 4-channel, 16-well, benchtop real-time PCR instrument that provides rapid results for batches of up to 16 samples, with integrated result interpretation in a device that occupies the compact footprint of a touch panel. Earlier, in 2022, the US FDA cleared the pixl platform for use with the BioGX Xfree COVID-19 Direct RT-PCR test EUA. BioGX offers an extensive menu of lyophilized multiplex syndromic panels for laboratory validation on the platform pixl, including the non-extraction Direct-Sample-to-Answer assays: Xfree Human Monkeypox (hMPXV), Xfree HSV1/HSV2/VZV, and Xfree Treponema pallidum (Syphilis). The Xfree assay format is compatible with most types of transport/collection media and can be validated for a wide variety of patient specimen collections. About BioGX BioGX is a world-leading provider of lyophilized real-time PCR reagents for molecular diagnosis. BioGX, Inc., headquartered in Birmingham, Alabama, and Dallas, Texas, and its subsidiary BioGX B.V., headquartered in Amsterdam, The Netherlands, (collectively "BioGX"), operate in a cGMP compliant environment and are certified to ISO 13485 medical device development and manufacturing standards. Patented Sample-Ready™ technology is at the core of all product offerings for clinical, food safety, pharmaceutical quality control, and water quality molecular testing. BioGX's more than 60 real-time multiplex PCR products are marketed and sold in multiple countries through its Global Distribution Network. For more information on BioGX, visit BioGX.com. Sample-Ready, Just Add Water, Xfree, and pixl are trademarks of BioGX, Inc.

ContactContact name: Mohammed MerchantContact description: Sr. Director, MarketingContact telephone: (205) 250-8055

NEXT NEWS